Last updated: July 11, 2026

Application No. 19/089,551

Untitled Application

Unknown

Filed

1600

Priority

Oct 23, 2023 — divisional of 12/281,143

Examiner

KOMATSU, LI N

Art Unit

1658

Tech Center

Solasta Bio Limited

Assignee

Solasta Bio Limited

OA Round

1 (Non-Final)

This examiner grants 60% of cases after interview

— +71.0% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 669 resolved cases, 2023–2026

Examiner Intelligence

KOMATSU, LI N View full profile →

Grants 60% of resolved cases

Career Allowance Rate

399 granted / 669 resolved

At TC average

Strong +71% interview lift

Without

With

+71.0%

Interview Lift

resolved cases with interview

Typical timeline

2y 7m

Avg Prosecution

61 currently pending

Career history

722

Total Applications

across all art units

Statute-Specific Performance

§101

1.1%

-38.9% vs TC avg

§103

39.3%

-0.7% vs TC avg

§102

9.2%

-30.8% vs TC avg

§112

12.4%

-27.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 669 resolved cases

Prosecution Timeline

1600

Application Filed

Apr 27, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/031,937

Patent 12667624

GIP DERIVATIVE, LONG-ACTING CONJUGATE THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

3y 2m to grant Granted Jun 30, 2026

17/919,940

Patent 12648572

PROTEOLYTICALLY STABLE U1-AGATOXIN-TA1B VARIANT POLYPEPTIDES FOR PEST CONTROL

3y 7m to grant Granted Jun 09, 2026

16/340,876

Patent 12642841

LIGANDS OF THE FSH HORMONE RECEPTOR IN THE DIAGNOSIS AND TREATMENT OF TUMORS

7y 1m to grant Granted Jun 02, 2026

18/812,797

Patent 12622948

GLP-1/GIP DUAL AGONISTS

1y 8m to grant Granted May 12, 2026

17/759,613

Patent 12606609

POLYPEPTIDES HAVING IMPROVED PROPERTIES

3y 8m to grant Granted Apr 21, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

60%

Grant Probability

99%

With Interview (+71.0%)

2y 7m

Median Time to Grant

Low

PTA Risk

Based on 669 resolved cases by this examiner. Grant probability derived from career allowance rate.